Related content

Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway

By Yao Jun   Qian Cuijuan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 1017-1022

Humana Press, Inc

Access to resources Recommend Favorite

ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine

By          

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 182-188

Spandidos Publications

Access to resources Recommend Favorite

A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells

By              

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 863-869

Spandidos Publications

Access to resources Recommend Favorite

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

By        

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1627-1635

Spandidos Publications

Access to resources Recommend Favorite

Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer

By            

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 792-798

Spandidos Publications

Access to resources Recommend Favorite